Table 3.

The association between tumor-infiltrating CD8+ CTLs, CD163+ M2 TAMs, Foxp3+ Tregs and clinicopathological features.

	CD8+ CTL		CD163+ M2 macrophage		Foxp3+ Treg
	median (IQR)	P	median (IQR)	P	median (IQR)	P
Age		0.700		0.108		0.854
<55 N=30	46 (34, 65)		92 (71, 117)		50 (29,83)
≥55 N=40	49 (23, 73)		113 (84, 149)		52 (29, 92)
Gender		0.667		0.914		0.872
male N=52	45 (27, 67)		100 (85, 134)		52 (30, 82)
female N=18	52 (19, 73)		104 (64, 157)		47 (26, 104)
differentiation, n (%)		0.321		0.343		0.955
poor/moderate N=48	45 (25, 64)		99 (78, 134)		53 (28, 95)
well N=22	57 (26, 104)		118 (81, 156)		46 (31, 78)
Histological type, n (%)		0.295		0.896		0.266
ulcerative	55 (35, 68)		99 (72, 143)		53 (30, 96)
N=39 other N=31	40 (23, 64)		102 (87, 138)		48 (25, 70)
T stage		0.431		0.750		0.644
T3 N=47	42 (27, 65)		101 (85, 143)		53 (33, 81)
T4 N=23	53 (25, 89)		99 (76, 138)		43 (25, 103)
N stage		0.260		0.026		0.418
N0 N=24	39 (17, 73)		89 (67, 116)		42 (25, 77)
N+ N=46	52 (29, 64)		108 (85, 145)		53 (30, 95)